Vestmark Advisory Solutions’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$658K Buy
+11,180
New +$683K 0.01% 1166

Other funds holding TVTX

Vestmark Advisory Solutions's TVTX Position: Q3 2026 in Review

Vestmark Advisory Solutions opened a new position in Travere Therapeutics (TVTX) in Q3 2026: 11,180 shares worth $658K. The stake represents 0.01% of the portfolio and ranks #1166 among its holdings.

345 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.

  • Vestmark Advisory Solutions held 11,180 shares of Travere Therapeutics worth $658K as of Q3 2026.
  • Travere Therapeutics was a new Vestmark Advisory Solutions position in Q3 2026.
  • Travere Therapeutics made up 0.01% of Vestmark Advisory Solutions's portfolio in Q3 2026, its #1166 holding.
  • 345 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q3 2026, filed 16 Nov 2026.